Serum Albumin at Partial Remission Predicts Outcomes in Membranous Nephropathy
Background: In primary membranous nephropathy (MN), partial remission (PR) (≥50% reduction of proteinuria to <3.5 g/d) is associated with a greater risk of relapse and end-stage kidney disease (ESKD) compared with complete remission (CR). We aimed to determine factors associated with relapse or r...
Main Authors: | Taewoo Lee, Yunro Chung, Caroline J. Poulton, Vimal K. Derebail, Susan L. Hogan, Heather N. Reich, Ronald J. Falk, Patrick H. Nachman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-05-01
|
Series: | Kidney International Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024920311037 |
Similar Items
-
Contraceptive Use and Elective Terminations in Women Enrolled in the Glomerular Disease Collaborative Network
by: Monica L. Reynolds, et al.
Published: (2020-10-01) -
Understanding Long-term Remission Off Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
by: Susan L. Hogan, et al.
Published: (2019-04-01) -
Using Glycated Albumin and Stimulated C-Peptide to Define Partial Remission in Type 1 Diabetes
by: Mei Shi, et al.
Published: (2022-07-01) -
Amadori albumin in diabetic nephropathy
by: Km. Neelofar, et al.
Published: (2015-01-01) -
Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy
by: Maxime Teisseyre, et al.
Published: (2021-10-01)